Dr. Zeinab Mohsenipour is a distinguished Iranian microbiologist whose scholarly focus and scientific achievements have advanced the field of Medical Bacteriology, particularly in the areas of antimicrobial resistance, bacterial biofilms, and bacteriophage therapy. She earned her Ph.D. in Medical Bacteriology from Tehran University of Medical Sciences, building on her earlier academic foundation with an M.Sc. in Microbiology and a B.A. in Biology from Shahid Bahonar University of Kerman. Throughout her academic and research journey, Dr. Mohsenipour has demonstrated an unwavering commitment to exploring the molecular and clinical mechanisms underlying infectious diseases. Her professional experience encompasses serving as a Research Assistant in the Bacteriology Laboratory at Tehran University of Medical Sciences and as a Lecturer at the University of Science and Culture, where she has taught undergraduate courses in microbial physiology, medical bacteriology, and microbial diversity. Beyond academia, she has also held an industry leadership role as Sales Manager at NojanTeb Azma Company, gaining practical insight into the intersection of scientific innovation and healthcare product development. Her research interests center on the study of antibiotic-resistant pathogens, biofilm inhibition, natural antimicrobial compounds, and the therapeutic application of predatory bacteria and bacteriophages. Dr. Mohsenipour possesses an extensive range of research skills, including bacterial culture and identification, PCR and molecular cloning, antibiotic susceptibility testing, and animal model experimentation, all of which contribute to her capacity for translational biomedical research. Her scientific productivity is evidenced by her numerous peer-reviewed publications in reputable journals indexed in Scopus, Frontiers, and BMC, addressing urgent microbiological issues such as lung infection models and bacterial-based drug delivery systems. Dr. Mohsenipour has also co-authored scientific books that enrich microbiological education, including An Overview of Monoclonal Antibodies: Production Methods and Applications and The Principle of Microbial Physiology. Her contributions have been recognized through invitations to serve as a reviewer for the European Journal of Clinical and Biomedical Sciences and through memberships in esteemed professional societies such as the American Society for Microbiology (ASM) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Dr. Mohsenipour’s excellence in both teaching and research reflects her passion for nurturing scientific inquiry and innovation. Her continuous involvement in international collaborations, advanced workshops, and cutting-edge bacteriological projects underscores her role as a promising and impactful researcher who is shaping the future of microbial science and global health improvement.

Profile: Scopus | ORCID | Google Scholar

Featured Publications 

1. Mohsenipour, Z., & Hassanshahian, M. (2015). The inhibitory effect of Thymus vulgaris extracts on the planktonic form and biofilm structures of six human pathogenic bacteria. Avicenna Journal of Phytomedicine, 5(4), 309–318. (Citations: 94)

2. Mohsenipour, Z., & Hassanshahian, M. (2015). The effects of Allium sativum extracts on biofilm formation and activities of six pathogenic bacteria. Jundishapur Journal of Microbiology, 8(8), e18971. (Citations: 78)

3. Mohsenipour, Z., & Hassanshahian, M. (2016). Antibacterial activity of Euphorbia hebecarpa alcoholic extracts against six human pathogenic bacteria in planktonic and biofilm forms. Jundishapur Journal of Microbiology, 9(6), e34701. (Citations: 63)

4. Omidinia, E., Shahbazmohammadi, H., & Mohsenipour, Z. (2019). Partitioning of recombinant Pseudomonas putida POS-F84 proline dehydrogenase in aqueous two-phase systems: Optimization using response surface methodology. Applied Biochemistry and Biotechnology, 189, 498–510. (Citations: 32)

5. Tajabadi, F. H., Karimian, S. M., Mohsenipour, Z., et al. (2022). Biocontrol treatment: Application of Bdellovibrio bacteriovorus HD100 against burn wound infection caused by Pseudomonas aeruginosa in mice. Burns: Journal of the International Society for Burn Injuries. (Citations: 19)

6. Mohsenipour, Z., Arazi, P., Skurnik, M., et al. (2024). Predation on bacterial pathogens by predatory bacteria of sewage origin: Three days prey-predator interactions. BMC Microbiology, 24, 516. (Citations: 12)

7. Mohsenipour, Z., Kianian, F., Jahanbin, B., Abtahi, H. R., Ghazanfari, T., Edalatifard, M., Amanpour, S., Skurnik, M., Arazi, P., & Feizabadi, M. M. (2025). Predatory bacteria can intensify lung injury in a multidrug-resistant Acinetobacter baumannii pneumonia model in rat. Frontiers in Microbiology, 16, 1512119. (Citations: 7)